Knightsbridge: Matt Ahern Explains ‘Painkillers’ and ‘Vitamins’

Knightsbridge Advisers LLC’s Matthew Ahern reminds us of the importance of ‘painkillers’ and ‘vitamins’ in venture capital, and his views on what they mean in periods of economic uncertainty. Watch episode 9 of our #200FromZero series below. ** The preceding is confidential and may not be distributed or reproduced without the express prior written consent of CAIS. The preceding is being provided for educational purposes only and is not, and should not be constructed as, an offer or solicitation to make an investment. CAIS is not making any representation or warranty with respect to the accuracy or completeness of the above information. The preceding information should not be relied upon in connection with any investment decision, or for any other purpose whatsoever. Past performance is not an indication of future results.